Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125558382 | 12555838 | 2 | F | 201606 | 20160705 | 20160714 | 20160719 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055568 | BRISTOL MYERS SQUIBB | 82.29 | YR | F | Y | 63.50000 | KG | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125558382 | 12555838 | 1 | PS | ELIQUIS | APIXABAN | 1 | Unknown | 2.5 MG, BID | AAF2694A | 202155 | 2.5 | MG | FILM-COATED TABLET | BID | |||||
| 125558382 | 12555838 | 2 | SS | TIKOSYN | DOFETILIDE | 1 | Oral | 0.25 MG, UNK | M25932 | 0 | .25 | MG | CAPSULE | BID | |||||
| 125558382 | 12555838 | 3 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | 18 MG, UNK | 0 | 18 | MG | QD | |||||||
| 125558382 | 12555838 | 4 | C | OXYGEN. | OXYGEN | 1 | Unknown | 3 L, UNK | 0 | 3 | L | ||||||||
| 125558382 | 12555838 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 40 MG, UNK | 0 | 40 | MG | CAPSULE | QD | ||||||
| 125558382 | 12555838 | 6 | C | PRESERVISION | MINERALSVITAMINS | 1 | Unknown | 1 DF, QD | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125558382 | 12555838 | 1 | Thrombosis prophylaxis |
| 125558382 | 12555838 | 2 | Atrial fibrillation |
| 125558382 | 12555838 | 3 | Chronic obstructive pulmonary disease |
| 125558382 | 12555838 | 4 | Chronic obstructive pulmonary disease |
| 125558382 | 12555838 | 5 | Gastrooesophageal reflux disease |
| 125558382 | 12555838 | 6 | Eye disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125558382 | 12555838 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125558382 | 12555838 | Arthralgia | |
| 125558382 | 12555838 | Chronic obstructive pulmonary disease | |
| 125558382 | 12555838 | Fatigue | |
| 125558382 | 12555838 | Headache | |
| 125558382 | 12555838 | Lethargy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125558382 | 12555838 | 1 | 201604 | 0 | ||
| 125558382 | 12555838 | 2 | 201604 | 0 |